| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2003; 42: 694-696
© 2003 British Society for Rheumatology
Letters to the Editor |
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report
Department of Internal Medicine Rheumatology Unit, University of Pisa and 1 Department of Histology, Microbiology and Medical Biotechnologies, University of Padova, Padova, Italy
| The first 10% of the full text of this article appears below. |
SIR, Systemic sclerosis (SSc) is a connective tissue disease characterized by collagen overproduction by altered fibroblasts and microvascular abnormalities, responsible for both visceral and skin involvement [1]. Vascular alterations lead to several typical manifestations of the disease, such as Raynaud's phenomenon and cutaneous ulcers. The latter are a frequent complication of SSc and are poorly responsive to the common pharmacological treatments. Vasodilator therapy with prostacyclin analogues has been reported to be effective in preventing and/or improving small cutaneous ulcers in some patients [2].
After the pioneering work of Rheinwald and Green in the mid-1970s [3], cultured keratinocyte grafting has become an alternative therapeutic approach to various ulcers (vascular, diabetic, post-traumatic) that are unresponsive to traditional treatments [4, 5
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Chitale, J. Watson, and A. Herrick Autologous skin grafting--a limb-saving procedure in a patient with diffuse cutaneous systemic sclerosis Rheumatology, March 1, 2008; 47(3): 379 - 380. [Full Text] [PDF] |
||||
